Gut Hormone Responses to Mixed Meal Test in New-Onset Prediabetes/Diabetes After Acute Pancreatitis.
Adult
Aged
Blood Glucose
Diabetes Mellitus, Type 2
/ blood
Dipeptidyl Peptidase 4
/ blood
Female
Gastric Inhibitory Polypeptide
/ blood
Gastrointestinal Hormones
/ blood
Glucagon
/ blood
Glucagon-Like Peptide 1
/ blood
Humans
Insulin
/ blood
Magnetic Resonance Imaging
Male
Meals
Middle Aged
Oxyntomodulin
/ blood
Pancreatitis
/ blood
Peptide YY
/ blood
Postprandial Period
/ physiology
Prediabetic State
/ blood
Subcutaneous Fat
/ diagnostic imaging
Journal
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
ISSN: 1439-4286
Titre abrégé: Horm Metab Res
Pays: Germany
ID NLM: 0177722
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
pubmed:
21
12
2018
medline:
18
6
2019
entrez:
21
12
2018
Statut:
ppublish
Résumé
The study was aimed to investigate gut hormone responses to mixed meal test in individuals with new-onset prediabetes or diabetes after acute pancreatitis (cases) compared with healthy controls, and the effect of body fat parameters. A total of 29 cases and 29 age- and sex-matched healthy controls were recruited. All participants were given standard mixed meal drink and blood samples were collected to measure dipeptidyl peptidase IV, gastric inhibitory peptide, glucagon like peptide-1, insulin, oxyntomodulin, and peptide YY. Body fat parameters were measured using magnetic resonance imaging. Repeated measures and linear regression analyses were conducted in unadjusted and adjusted models. Gastric inhibitory peptide levels were significantly higher whereas oxyntomodulin levels were significantly lower in cases compared with controls in both the unadjusted (p<0.001 and p<0.001, respectively) and adjusted (p<0.001 and p<0.001, respectively) models. In cases, liver fat % contributed up to 13.4% (vs. 2.9% in controls) to variance in circulating levels of gastric inhibitory peptide whereas body mass index - up to 20.8% (vs. 9.9% in controls) in circulating levels of oxyntomodulin. New-onset prediabetes/diabetes after acute pancreatitis is characterised by increased levels of gastric inhibitory peptide and decreased levels of oxyntomodulin. Further, liver fat % and body mass index appear to be the body fat parameters that contribute most significantly to gastric inhibitory peptide and oxyntomodulin levels, respectively.
Substances chimiques
Blood Glucose
0
Gastrointestinal Hormones
0
Insulin
0
Oxyntomodulin
0
Peptide YY
106388-42-5
Gastric Inhibitory Polypeptide
59392-49-3
Glucagon-Like Peptide 1
89750-14-1
Glucagon
9007-92-5
Dipeptidyl Peptidase 4
EC 3.4.14.5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
191-199Informations de copyright
© Georg Thieme Verlag KG Stuttgart · New York.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.